
Supporting EUA data for the one-shot vaccine candidate showed Americans fared best in a 40,000-participant, international trial.
Supporting EUA data for the one-shot vaccine candidate showed Americans fared best in a 40,000-participant, international trial.
Investigators sought to compare trends in US pediatric hospitalizations in 2020 with those the decade prior to COVID-19.
A talk on optimistic, but pragmatic hopes for HIV cure and vaccine research, led by federal-level experts.
TicoVac will be decided on for both pediatric and adult people at risk of the tick-borne virus in August.
SAP1 and SAP6 were found to inhibit a SARS-CoV-2 infection.
Understanding underlying immunological mechanisms can provide critical insights.
In addition to 7 people in 4 states who have become sick after eating queso fresco from a New Jersey-based company, the Food and Drug Administration (FDA) has published an updated warning.
An investigational HCV vaccine induced immunologic response and was well tolerated, but did not protect against infection.
Attention to the endemic virus has lessened over years, and screening and prevention access remains limited among the most at-risk groups.
This partnership of recognized experts provided feedback about a variety of topics related to the virus.
The new advisory is informed by currently-understood effect of authorized vaccines against circulating SARS-CoV-2—which show benefit nonetheless.
According to the federal agency, anaphylaxis from mRNA COVID-19 vaccinations is a rare event.
Mediterranean region imposes partial lockdown following a surge in cases.
A John Hopkins expert and major study leader details the evolving epidemiology of the virus.
Investigators at Cedars-Sinai Medical Center identified a variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called CAL.20C, which accounted for about 44% of samples in Southern California in January.
HIV-associated wasting remains common complication despite treatment with antiretroviral therapy.
Immune memory is the basis for durable protective immunity after infections or vaccinations.
The news comes on the same day as new data showing the vaccine's efficacy as a single-dose prophylactic, as well as the company's application for eased storage standards for US supplies.
With millions of mRNA vaccine doses administered, the US Centers for Disease Control and Prevention (CDC) provide information on these events.
The session was part of the COVID-19 Real Time Learning Network.
The biweekly webinars hosted by renowned health care thought leaders provide resources to improve patient outcomes during COVID-19. Here's a recap of the first 5 discussions.
The interval between doses can be safely extended to 3 months given the protection a single dose offers.
Ruth Coker Burks’ new book, All the Young Men, chronicles her years at the bedside of victims.
An Israeli study finds it had an 85% effect in lowering disease 2 to 4 weeks after administration of the initial vaccination.
Children are about half as susceptible as adults to contracting COVID-19, according to new research from Israel.
Findings may be valuable in situations where there is a limited testing capacity.
Findings indicate potential ways to identify individuals at higher or lower risk.
HIV testing and initiation of antiretroviral therapy (ART) fell in South Africa during the national lockdown in response to the coronavirus disease 2019 (COVID-19) pandemic, a new study shows.
In lab studies, neutralizing antibody activity was reported but there was a reduction shown in both m-RNA vaccines.